Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,975 | 120,229 | 139,978 | 176,978 | 140,435 |
| TOTAL | $83,726 | $130,777 | $151,139 | $191,747 | $152,989 |
| Non-Current Assets | |||||
| PPE Net | 93,991 | 93,814 | 90,307 | 83,099 | 69,588 |
| Intangibles | 0 | 120 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,371 | 979 | 1,200 | 1,319 | 1,139 |
| TOTAL | $95,362 | $94,913 | $91,507 | $84,418 | $70,727 |
| Total Assets | $179,088 | $225,690 | $242,646 | $276,165 | $223,716 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,016 | 8,068 | 4,556 | 9,568 | 9,397 |
| Accrued Expenses | 4,619 | 9,680 | 8,280 | 5,830 | 5,560 |
| TOTAL | $13,073 | $18,180 | $13,340 | $15,909 | $15,354 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 588 | 328 | 382 | 31,974 | 405 |
| TOTAL | $588 | $328 | $382 | $31,974 | $405 |
| Total Liabilities | $13,661 | $18,508 | $13,722 | $47,883 | $15,759 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 3 | 3 | 2 | 599,680 |
| Common Shares | 64 | 12 | 53 | 32 | 553 |
| Retained earnings | -516,992 | -470,038 | -438,358 | -409,377 | -386,237 |
| Other shareholders' equity | -211 | -167 | -160 | -143 | -118 |
| TOTAL | $165,427 | $207,182 | $228,924 | $228,282 | $207,957 |
| Total Liabilities And Equity | $179,088 | $225,690 | $242,646 | $276,165 | $223,716 |